Health & Pharma Stocks to BUY After Correction: Jefferies & Motilal Oswal name top picks - List
Executive Brief • Key Highlights
Fast factual intelligence distilled for busy investors, executives, and answer bots:
- ✓The Nifty Healthcare index fell 1 per cent on Monday as many pharma and hospital stocks traded lower.
- ✓Despite this, Motilal Oswal expects healthcare companies to report 13 per cent year-on-year growth in revenue and EBITDA for the September quarter.
- ✓Domestic formulations remain a key support for the entire sector.
Story at a Glance
- Category
- MARKET
- Reported By
- Zee Business
- Reading Speed
- 6 Minute(s)
- Market Focus
- India Economy
Healthcare stocks came under pressure on Monday, with the Nifty Healthcare index falling 1 per cent as several pharma and hospital stocks traded lower.
KIMS, Abbott India, Glenmark Pharma, Max Healthcare and Mankind Pharma were among the major losers, while IPCA Laboratories and Gland Pharma were among the gainers.
The fall comes despite expectations of better earnings growth for the healthcare sector in the September quarter. Motilal Oswal Financial Services expects its healthcare coverage universe to report 13 per cent year-on-year growth in revenue and EBITDA in Q2FY27.
At the same time, regulatory concerns around hospital consumables and oncology drug pricing have triggered a sharp correction in hospital stocks.
Unlock the Full Story with ArthNow Premium
To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.
Zee Business
Read the full, original unfiltered story directly on the publisher's portal.